University of Texas Southwestern Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Texas Southwestern Medical Center sits in the top decile of US sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count).
University of Texas Southwestern Medical Center: 837 sponsored US clinical trials, 162 recruiting.
University of Texas Southwestern Medical Center sponsors 837 registered US clinical trials on ClinicalTrials.gov, 162 of them currently recruiting, and 503 completed. 126 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 9 trials.
Top-decile sponsor footprint
University of Texas Southwestern Medical Center ranks in the top decile of sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
503 of 608 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
837 total, page 16 of 17
Study on the Role of Decompression of Lower Extremity Nerves for the Treatment of Patients With Symptomatic Diabetic Neuropathy With Chronic Nerve Compression
NCT00703209
The Efficacy of Hand Narrow-Band Ultraviolet B (NBUVB) Versus Excilite Treatment in Vitiligo After Minigrafting on the Dorsal Hands
NCT00622180
Phenytoin as a Neuroprotective Agent Against Corticosteroid-induced Functional Imaging Changes
NCT00591006
Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda
NCT00599326
Neurophysiological Studies in Schizophrenia and Psychiatric Disorders
NCT01384604
Tear Film Stability After Instillation of Over-the-Counter (OTC) Artificial Drops
NCT00610480
Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia
NCT00690235
Sodium Restriction in the Management of Cirrhotic Ascites
NCT00548366
Effect of Dietary Macronutrient Composition
NCT01371396
Role of Pancreatic Triglyceride Content in Beta-cell Function
NCT00602953
Dallas Heart Study 2: Return Clinic Visit for the Dallas Heart Study Cohort
NCT00344903
Stress, Hypothalamic-pituitary-adrenal (HPA) Dysfunction, and Relapse in Alcoholism
NCT00744588
Non-Interventional F-Two Isoprostane Trial (NIFTI)
NCT00505908
The Effect of Low Intensity Exercise on Quality of Life and Hemodynamics in Patients With Permanent Atrial Fibrillation
NCT00680290
Erlotinib and SBRT in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT00547105
Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon
NCT00642694
Oral Misoprostol for Labor Augmentation: A Pilot Study
NCT00906126
Impulsivity, Neural Deficits and Cocaine Addiction
NCT00744601
Quetiapine for Bipolar Disorder and Alcohol Dependence
NCT00457197
Early Experience With Descemet's Stripping Automated Endothelial Keratoplasty
NCT00744796
Postoperative Pain and Morphine Consumption After Mastectomy - Lyrica
NCT01391858
Acetaminophen (Tylenol) for Mood and Memory Changes Associated With Corticosteroid Therapy
NCT00377364
A Pilot Study of Citicoline add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or Dependence
NCT00377299
Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH
NCT00564018
Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer
NCT00547339
Pharmacokinetics of Low Dose Ketamine Infusion
NCT00618397
Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple Sclerosis
NCT00324506
Novel Therapies for Metabolic Complications of Lipodystrophies
NCT00457938
RFT-5-dgA in Patients With Metastatic Melanoma
NCT00314093
Trial of Leptin Replacement Therapy in Patients With Lipodystrophy
NCT00896298
Cholic Acid for Hepatic Steatosis in Lipodystrophy
NCT00457639
Pharmacokinetic Response to BPI in Burns
NCT00462904
Memantine for Corticosteroid-Induced Mood and Declarative Memory Changes
NCT00280774
Clinical Outcomes After AcrySof® ReStor IOL Surgery in Faculty Practice at UTSW Medical Center at Dallas: A Retrospective Review
NCT00344578
Lamotrigine add-on Therapy for Bipolar Disorder and Cocaine Dependency
NCT00280293
Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma
NCT00295503
Effects of Systane Versus Saline in Maintaining Tear Film Stability at Determined Time Points
NCT00345241
A Prospective Clinical Research Project Evaluating The Effects of Soft Contact Lenses on Higher Order Visual Aberrations
NCT00344864
An Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine Dependence
NCT00223210
Memantine or Riluzole Prophylaxis for Corticosteroid-induced Mood and Declarative Memory Changes
NCT00283309
Aripiprazole Augmentation of SSRI Therapy in Treatment Refractory Depression
NCT00608543
Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence
NCT00300235
Laparoscopic Simulator Training and Its Impact on Surgical Education
NCT00555243
Efficacy of Esomeprazole for Non-Allergic Rhinitis: A Double-blind, Placebo Controlled Trial
NCT00745849
Naltrexone for Bipolar Disorder and Alcohol Dependence
NCT00223275
Comparison of Higher Order Aberrations and Contrast Sensitivity Between Acrysof SN60AT, SN60WF and Restore Intraocular Lenses
NCT00345085
Comparison of Efficacy and Safety of Ezetimibe or Statin Monotherapy to Co-Administration of Both
NCT00461968
Assessment of Cognitive Functioning Before and After Treatment With Duloxetine
NCT00933439
Levetiracetam for Neuroprotection Against Corticosteroid-induced Hippocampal Dysfunction: A Proof of Concept Study
NCT00223223
Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial Triglyceride
NCT00424762
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 106 |
| Phase 2 | 122 |
| Phase 3 | 28 |
| Phase 4 | 98 |
Therapeutic Areas
What is open in the University of Texas Southwestern Medical Center pipeline
162 recruiting of 837 indexed (19% open); 503 completed (60%).
Phase mix: 126 late (III/IV) vs 228 early (I/II) (early-phase heavy).
Top condition: Hypertension (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Texas Southwestern Medical Center: open-pipeline peers nationwide
Peers matched on 837 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Texas Southwestern Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 837 trials (± recruiting share)
- University of Utah · 818 trials · 17% recruiting
- University of Chicago · 796 trials · 20% recruiting
- Indiana University · 890 trials · 18% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
Sponsors near 19% open enrollment (± trial volume)
- California Polytechnic State University-San Luis Obispo · 19% recruiting · 26 trials
- Phoenix Children's Hospital · 19% recruiting · 26 trials
- Ann & Robert H Lurie Children's Hospital of Chicago · 19% recruiting · 159 trials
- Vanderbilt University Medical Center · 19% recruiting · 677 trials
Related
What to do with this University of Texas Southwestern Medical Center page
837 registered trials is a research-attention snapshot, not an endorsement of University of Texas Southwestern Medical Center or any single study.
- 162 of University of Texas Southwestern Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension is the condition University of Texas Southwestern Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Texas Southwestern Medical Center pipeline card: 837 registered trials from official public datasets.Report a data error.